Snowden Capital Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$310K Buy
4,932
+122
+3% +$8.5K 0.01% 1009
2025
Q4
$319K Sell
4,810
-676
-12% -$43.7K 0.01% 1024
2025
Q3
$369K Sell
5,486
-150
-3% -$11.9K 0.01% 936
2025
Q2
$492K Sell
5,636
-2,337
-29% -$183K 0.01% 773
2025
Q1
$544K Sell
7,973
-197
-2% -$16.1K 0.02% 702
2024
Q4
$635K Buy
8,170
+1,548
+23% +$115K 0.02% 672
2024
Q3
$444K Sell
6,622
-1,215
-16% -$99.8K 0.01% 824
2024
Q2
$889K Buy
7,837
+466
+6% +$58.9K 0.03% 542
2024
Q1
$1.02M Buy
7,371
+1,803
+32% +$227K 0.03% 498
2023
Q4
$691K Buy
5,568
+471
+9% +$48.1K 0.03% 553
2023
Q3
$476K Sell
5,097
-1,978
-28% -$223K 0.02% 678
2023
Q2
$909K Sell
7,075
-413
-6% -$50K 0.03% 485
2023
Q1
$870K Sell
7,488
-1,257
-14% -$141K 0.03% 494
2022
Q4
$990K Buy
8,745
+1,796
+26% +$197K 0.04% 451
2022
Q3
$559K Buy
6,949
+63
+0.9% +$5.34K 0.03% 606
2022
Q2
$513K Buy
6,886
+3,322
+93% +$303K 0.02% 618
2022
Q1
$455K Buy
3,564
+3,352
+1,581% +$367K 0.02% 661
2021
Q4
$28K Sell
212
-2,136
-91% -$307K ﹤0.01% 1204
2021
Q3
$321K Buy
2,348
+8
+0.3% +$1.01K 0.02% 665
2021
Q2
$250K Buy
+2,340
New +$225K 0.01% 772

Other funds holding DXCM

Snowden Capital Advisors's DXCM Position: Q1 2026 in Review

Snowden Capital Advisors increased its DexCom (DXCM) stake by 2.5% in Q1 2026, buying an estimated $8.5K and bringing the position to 4,932 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #1009.

Snowden Capital Advisors first reported a position in DXCM in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.02M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Snowden Capital Advisors held 4,932 shares of DexCom worth $310K as of Q1 2026.
  • Snowden Capital Advisors bought 122 DexCom shares in Q1 2026, an estimated $8.5K.
  • DexCom made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #1009 holding.
  • Snowden Capital Advisors first reported a position in DexCom in Q2 2021 and has held it in 20 quarters since.
  • Snowden Capital Advisors's DexCom position peaked at $1.02M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.